Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-26

FDA Approved: LINCOMYCIN — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved Sagent Pharmaceuticals' LINCOMYCIN hydrochloride as a generic antibiotic under an original ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LINCOMYCIN (LINCOMYCIN HYDROCHLORIDE)

Snippet

ORIG AP for LINCOMYCIN (LINCOMYCIN HYDROCHLORIDE)